Skip to main content
. 2016 Mar 21;7(18):25549–25557. doi: 10.18632/oncotarget.8224

Table 4. Grade 3 or 4 AEs considered to be related to the Cidofovir and chemoradiotherapy combination (weeks 1 to 10) in the 15 patients.

G3-4 AEs Tota Related to treatment
N (%) N (%)
Abdominal pain 3 2
Infection 2 1
Leukoneutropenia 2 2
Proteinuria 1 1
Myalgia 1 0
Vaginal bleeding 1 0
Asthenia 1 0
Insomnia 1 0
Hyperglycemia 1 0

AEs: adverse events, N: number of patients.